| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | 0.00096 | 1 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00078 | 1 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.00076 | 1 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.00085 | 1 |